Can Zytiga Build on a Historic 2012?
Motley Fool
Big News for This Blockbuster Drug
Motley Fool
Dendreon Dodges A Bullet
Seeking Alpha
FDA approves J&J's Zytiga for men who have not yet received chemotherapy for prostate tumors
Yahoo/AP

